HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$7.53
Day range
$6.72 - $7.60
Year range
$2.14 - $12.82
Market cap
156.14M USD
Avg Volume
60.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.80M | 51.42% |
Net income | -10.00M | 54.61% |
Net profit margin | — | — |
Earnings per share | -0.44 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.98M | 7,098.41% |
Total assets | 121.74M | 1,875.59% |
Total liabilities | 42.92M | -24.41% |
Total equity | 78.81M | — |
Shares outstanding | 19.45M | — |
Price to book | 1.86 | — |
Return on assets | -26.61% | — |
Return on capital | -44.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.00M | 54.61% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
Employees
14
